Index of Severity for Eosinophilic Esophagitis (I-SEE)

ورودی‌های بالینی بیمار

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
score
—points
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Inactive0–0
  • Mild1–6
  • Moderate7–14
  • Severe15–45
Direct Clinical Answer

The Index of Severity for Eosinophilic Esophagitis (I-SEE) calculates assessing gastrointestinal disease severity, endoscopic intervention urgency, and rebleeding risk. Key inputs include symptoms frequency. Scores guide timing emergent endoscopy, initiating high-dose proton pump inhibitor infusions, or obtaining surgical consultation. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

Classifies severity of eosinophilic esophagitis (EoE) using a comprehensive scoring system that evaluates symptoms, complications, inflammatory features, and fibrostenotic changes. The I-SEE was developed by a multidisciplinary international group of EoE experts to standardize disease severity assessment beyond eosinophil counts alone. This validated clinical tool helps guide practitioners in EoE management by providing standardized disease severity classification that correlates with clinical features, treatment response, and need for interventions such as dilation. The score evaluates multiple domains including symptom frequency, complications (food impaction, hospitalization), inflammatory features (edema, furrows, exudates, eosinophil counts), and fibrostenotic features (rings, strictures) to provide a comprehensive assessment of disease severity.

Clinical Indication

The Index of Severity for Eosinophilic Esophagitis (I-SEE) is indicated for bedside clinical practice to support Classifies severity of eosinophilic esophagitis (EoE) using a comprehensive scoring system that evaluates symptoms, complications, inflammatory features, and fibrostenotic changes. The I-SEE was developed by a multidisciplinary international group of EoE experts to standardize disease severity assessment beyond eosinophil counts alone. This validated clinical tool helps guide practitioners in EoE management by providing standardized disease severity classification that correlates with clinical features, treatment response, and need for interventions such as dilation. The score evaluates multiple domains including symptom frequency, complications (food impaction, hospitalization), inflammatory features (edema, furrows, exudates, eosinophil counts), and fibrostenotic features (rings, strictures) to provide a comprehensive assessment of disease severity.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients presenting with upper or lower gastrointestinal hemorrhage, acute pancreatitis, acute liver failure, or inflammatory bowel disease. Clinical application is indicated across Endoscopy suites, emergency GI triage, acute medical floors, and hepatology services.

Limitations & Contraindications

Initial hemoglobin values in hyperacute hemorrhage may falsely appear normal prior to complete extravascular-to-intravascular fluid equilibration.

Clinical Pearls & Action Plan

Aggressive intravascular volume resuscitation and blood product support must precede diagnostic or therapeutic endoscopy. Guideline pearl: Severity improves with successful topical corticosteroid treatment.

Formula & Variables:

Score = Symptoms (0-4) + Food impaction (0-4) + Hospitalization (0-4) + Perforation (0-15) + Malnutrition (0-15) + Persistent inflammation (0-15) + Inflammatory features (0-2) + Eosinophil count (0-2) + Rings/strictures (0-15)

Input Parameters

NameTypeRequiredDescription
symptoms_frequencystringYesFrequency of EoE-related symptoms (dysphagia, food getting stuck, chest pain, heartburn). Symptom frequency correlates with disease activity and quality of life impact
food_impactionstringYesHistory of food impaction requiring emergency room visit or endoscopic removal. Food impaction is a serious complication that may require urgent intervention and indicates significant esophageal dysfunction
hospitalization_due_eoestringYesHospitalization specifically due to EoE-related complications. Hospitalization indicates severe disease requiring inpatient management and represents significant healthcare burden
esophageal_perforationstringYesHistory of esophageal perforation. Perforation is the most serious complication of EoE, often requiring surgical intervention and carrying significant morbidity risk
malnutritionstringYesMalnutrition defined as body mass <5th percentile or decreased growth velocity. Malnutrition indicates severe functional impact affecting nutritional status and growth, particularly important in pediatric patients
persistent_inflammationstringYesPersistent inflammation requiring special treatments (immunosuppressives, biologics, elimination diets). Indicates refractory disease requiring advanced therapeutic interventions beyond standard topical steroids
inflammatory_featuresstringYesEndoscopic inflammatory features: edema, furrows, and exudates (EFE). These findings represent active inflammatory changes in the esophageal mucosa and correlate with disease activity
eosinophil_countstringYesPeak eosinophil count per high-power field (eos/hpf) on esophageal biopsy. Eosinophil count is the hallmark histologic feature of EoE, with ≥15 eos/hpf required for diagnosis
rings_stricturesstringYesPresence and severity of esophageal rings or strictures. Fibrostenotic changes represent chronic remodeling and may require mechanical intervention (dilation) for symptom relief

Score Interpretation & Guidance

RangeStageDescription
0–0InactiveScore 0 points
1–6MildScore 1-6 points
7–14ModerateScore 7-14 points
15–45SevereScore ≥15 points

Evidence-Based References (EBM)

  • Hirano I, Aceves SS, Blanchard C, et al. A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions. Gastroenterology. 2022 Jul;163(1):59-76.e16. doi: 10.1053/j.gastro.2022.02.048.DOI: 10.1053/j.gastro.2022.02.048
  • Rank MA, Shaffer K, Campion J, et al. A newly proposed severity index for eosinophilic esophagitis is associated with baseline clinical features and successful treatment response. Clin Gastroenterol Hepatol. 2023 Oct;21(11):2890-2897.e2. doi: 10.1016/j.cgh.2023.04.013.DOI: 10.1016/j.cgh.2023.04.013
  • Stern E, Schoepfer A, Spechler SJ, et al. The Index of Severity for Eosinophilic Esophagitis (I-SEE) Reflects Longitudinal Clinicopathologic Changes in Children. J Pediatr Gastroenterol Nutr. 2023 Dec;77(6):743-749. doi: 10.1097/MPG.0000000000003928.DOI: 10.1097/MPG.0000000000003928

Related calculators